DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Xeloda (Capecitabine) - Dehydration - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dehydration (150)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Xeloda (Capecitabine) where reactions include dehydration. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 150   Next >>

Possible Xeloda side effects in female

Reported by a physician from Germany on 2012-08-24

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Dehydration, Bradyarrhythmia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Breast Cancer

Vinorelbine Tartrate
    Indication: Breast Cancer

Xeloda
    Indication: Breast Cancer



Possible Xeloda side effects in female

Reported by a physician from Australia on 2012-08-24

Patient: female, weighing 109.0 kg (239.8 pounds)

Reactions: Nausea, Urinary Tract Infection, Atrial Fibrillation, Pyrexia, Anastomotic Leak, Hypokalaemia, Diarrhoea, Ventricular Tachycardia, Dehydration, Hypoalbuminaemia, Decreased Appetite, Anastomotic Fistula

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Oxaliplatin
    Dosage: last dose prior to sae on 21mar 2011 (50 mg/m2 on day1, 8, 15, 21 and 29).
    Indication: Rectal Cancer
    Start date: 2011-02-21
    End date: 2011-08-10

Xeloda
    Dosage: last date prior to sae: 26 march 2011 250 mg. (825 mg/m2 bid d1-33 w/o weekends and optional boost),
    Administration route: Oral
    Indication: Rectal Cancer
    Start date: 2011-02-21
    End date: 2011-08-10

Other drugs received by patient: Salmeterol; Colecalciferol; Potassium; Aspirin; Fluticasone Propionate; Pantoprazole; Prednisolone; Methotrexate; Acetaminophen; Metoprolol Tartrate; Diclofenac Sodium; Ferrous Sulfate TAB; Olmesartan Medoxomil; Enoxaparin; Folic Acid; Magnesium; Verapamil; Metoclopramide



Possible Xeloda side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22

Patient: male, weighing 89.9 kg (197.8 pounds)

Reactions: Vomiting, Dyspnoea, Nausea, Dehydration, Pneumomediastinum, Pneumothorax, Odynophagia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Oesophageal Cancer Metastatic
    Start date: 2011-05-17
    End date: 2011-11-15

Avastin
    Dosage: last dose recieved on 14 feb 2012
    End date: 2012-02-14

Herceptin
    Dosage: last dose recieved on 14 feb 2012.
    End date: 2012-02-14

Herceptin
    Dosage: last dose recieved on 14 feb 2012.
    Indication: Oesophageal Cancer Metastatic
    Start date: 2011-05-10
    End date: 2011-11-15

Oxaliplatin
    Indication: Oesophageal Cancer Metastatic
    Start date: 2011-05-17
    End date: 2011-11-15

Oxaliplatin
    End date: 2012-02-14

Xeloda
    End date: 2012-02-26

Xeloda
    Indication: Oesophageal Cancer Metastatic
    Start date: 2011-05-17
    End date: 2011-11-29

Other drugs received by patient: Actos; Lorazepam; DTO; Prilosec; Ritalin; Toprol-XL; Potassium Chloride; Lomotil; Dexamethasone; Compazine; Prednisone TAB; Citalopram Hydrobromide; Morphine Sulfate; Lisinopril; Metoprolol Tartrate; Dicyclomine; Methylphenidate; Zofran; Oxycodone HCL; Decadron Phosphate; Bentyl; Emend



Possible Xeloda side effects in 60 year old female

Reported by a physician from Canada on 2012-08-20

Patient: 60 year old female

Reactions: Vomiting, Nausea, Diarrhoea, Neoplasm Malignant, Dehydration, Disease Progression, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Tykerb
    Administration route: Oral

Tykerb
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Xeloda
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Hydromorphone Hydrochloride; Retinol; Prevacid; Micardis; Verapamil HCL; Celebrex; Colace; Vitamin D; Antihypertensive Medications; Actonel; Senokot



Possible Xeloda side effects in female

Reported by a physician from Germany on 2012-08-20

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Syncope, Supraventricular Tachycardia, Dehydration, Pulmonary Oedema

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Avastin
    Dosage: 1 x 90 minutes. last dose prior to sae was taken on 11/jul/2012
    Indication: Colorectal Cancer Metastatic
    Start date: 2012-07-11

Irinotecan Hydrochloride
    Dosage: 1 x 2 hours
    Indication: Colorectal Cancer Metastatic

Irinotecan Hydrochloride
    Start date: 2012-08-01

Xeloda
    Dosage: 2 tablets in the morning and 2 tablets in the evening.
    Administration route: Oral
    Start date: 2012-08-01

Xeloda
    Dosage: 3 tablets in the morning and 2 tablets in the evening. last dose prior to sae was taken on 24/jul/20
    Indication: Colorectal Cancer Metastatic
    Start date: 2012-07-11



Possible Xeloda side effects in female

Reported by a physician from Germany on 2012-08-20

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Dehydration, Bradyarrhythmia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Breast Cancer

Vinorelbine Tartrate
    Indication: Breast Cancer

Xeloda
    Indication: Breast Cancer



Possible Xeloda side effects in 62 year old female

Reported by a consumer/non-health professional from Canada on 2012-08-20

Patient: 62 year old female

Reactions: Stomatitis, Renal Failure, Blood Potassium Decreased, Diarrhoea, Oral Pain, Skin Ulcer, Dehydration, Blood Sodium Decreased, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tykerb
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Xeloda
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Laxatives (Unk Ingredients); Metoclopramide; Desmopressin Acetate (Ddavp); Dexamethasone; Metoprolol Tartrate; Vitamin D; Hydromorphone Hydrochloride; Spironolactone; Aspirin; Slow-K; Pantoprazole



Possible Xeloda side effects in female

Reported by a pharmacist from United States on 2012-08-15

Patient: female

Reactions: Weight Decreased, Diarrhoea, Dehydration, Hypotension, Platelet Count Decreased

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-13

Patient:

Reactions: Abdominal Pain, Blood Bilirubin Increased, Thrombosis, Anal Examination Abnormal, Hypokalaemia, Fatigue, Proteinuria, Abdominal Distension, Decreased Appetite, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Hyponatraemia, Small Intestinal Obstruction, Hypophosphataemia, Diarrhoea, Alopecia, Dehydration, Neutropenia, Hypertension, Vascular Access Complication

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin
    Dosage: given on day 1
    Indication: Colorectal Cancer Metastatic

Irinotecan Hydrochloride and Irinotecan Hydrochloride
    Dosage: given on day 1
    Indication: Colorectal Cancer Metastatic

Xeloda
    Dosage: 1000 mg/m2 twice daily for age below 65 years,750 mg/m2 twice daily for age above 65 years
    Administration route: Oral
    Indication: Colorectal Cancer Metastatic



Possible Xeloda side effects in female

Reported by a physician from Japan on 2012-08-08

Patient: female, weighing 55.0 kg (121.0 pounds)

Reactions: Dehydration, Device Related Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-01-07
    End date: 2011-03-05

Tykerb
    Dosage: 1000mg per day
    Administration route: Oral
    Start date: 2011-04-08

Xeloda
    Dosage: 2400mg per day
    Administration route: Oral
    Start date: 2010-10-28
    End date: 2011-03-09

Xeloda
    Dosage: 1800mg per day
    Administration route: Oral
    Start date: 2011-04-07

Other drugs received by patient: Omeprazole; Mobic; Juvela; Alendronate Sodium; Artist; Vesicare; Gaslon N; Calblock; Locoid; Uritos; White Soft Paraffin



Possible Xeloda side effects in female

Reported by a physician from United States on 2012-08-07

Patient: female, weighing 72.9 kg (160.4 pounds)

Reactions: Mucosal Inflammation, Blood Bilirubin Increased, Malaise, Dyspnoea, Dehydration, Palmar-Plantar Erythrodysaesthesia Syndrome, Constipation, Ascites

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ramucirumab
    Indication: Breast Cancer
    Start date: 2012-06-15

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-06-15

Other drugs received by patient: Tramadol HCL; Ativan; Compazine; Lisinopril



Possible Xeloda side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: male, weighing 63.1 kg (138.8 pounds)

Reactions: Diarrhoea, Dehydration, Pancreatitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin Hydrochloride
    Indication: Oesophageal Carcinoma
    Start date: 2012-04-18

Xeloda
    Administration route: Oral
    Indication: Oesophageal Carcinoma
    Start date: 2012-04-19
    End date: 2012-05-16

Xeloda
    Administration route: Oral
    Start date: 2012-04-18
    End date: 2012-07-14



Possible Xeloda side effects in female

Reported by a consumer/non-health professional from Canada on 2012-08-01

Patient: female

Reactions: Nausea, Hypotension, Neoplasm Progression, Hepatic Neoplasm, Fatigue, Lung Disorder, Diarrhoea, Dehydration, Asthenia, Decreased Appetite

Drug(s) suspected as cause:
Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-05-18

Xeloda
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Ramipril



Possible Xeloda side effects in 62 year old female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-30

Patient: 62 year old female, weighing 63.0 kg (138.6 pounds)

Reactions: Diarrhoea, Metastases To Liver, Dehydration, Febrile Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Oxaliplatin
    Dosage: 130 mg/m 2 milligram(s)/sq. meter
    Indication: Colorectal Cancer Metastatic

Xeloda
    Dosage: 2000 mg/m 2 milligram(s)/sq. meter
    Indication: Colorectal Cancer Metastatic



Possible Xeloda side effects in female

Reported by a physician from Germany on 2012-07-30

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Syncope, Dehydration, Pulmonary Oedema

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Avastin
    Dosage: 1 x 90 minutes
    Indication: Colorectal Cancer Metastatic

Irinotecan HCL
    Dosage: 1 x 2 hours
    Indication: Colorectal Cancer Metastatic

Xeloda
    Dosage: 3 tablets in the morning and 2 tablets in the evening
    Indication: Colorectal Cancer Metastatic
    Start date: 2012-07-11



Possible Xeloda side effects in 60 year old female

Reported by a physician from Germany on 2012-07-25

Patient: 60 year old female

Reactions: Mucosal Inflammation, Renal Failure, Dehydration, Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer
    Start date: 2012-01-01

Xeloda
    Indication: Breast Cancer
    Start date: 2012-01-01

Other drugs received by patient: Metformin Hydrochloride



Possible Xeloda side effects in 62 year old female

Reported by a consumer/non-health professional from Denmark on 2012-07-24

Patient: 62 year old female, weighing 63.0 kg (138.6 pounds)

Reactions: Diarrhoea, Dehydration, Febrile Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Oxaliplatin

Xeloda
    Dosage: dosis: 2000 mg/m2 d. 1-14. frequency: 1 every 14 days
    Administration route: Oral

Xeloda
    Dosage: dosis: 2000 mg/m2 d. 1-14. frequency: 1 every 14 days
    Administration route: Oral



Possible Xeloda side effects in female

Reported by a physician from Germany on 2012-07-24

Patient: female, weighing 67.0 kg (147.4 pounds)

Reactions: Hypotension, Dehydration, Hypothyroidism

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Breast Cancer Metastatic

Xeloda
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    End date: 2012-07-09

Other drugs received by patient: Voltaren; Oxycodone Hydrochloride; Pantoprazole



Possible Xeloda side effects in female

Reported by a physician from United States on 2012-07-23

Patient: female, weighing 72.9 kg (160.4 pounds)

Reactions: Blood Bilirubin Increased, Mucosal Inflammation, Dyspnoea, Malaise, Dehydration, Palmar-Plantar Erythrodysaesthesia Syndrome, Constipation, Ascites

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ramucirumab
    Indication: Breast Cancer
    Start date: 2012-06-15

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-06-15

Other drugs received by patient: Compazine; Tramadol Hydrochloride; Lisinopril; Ativan



Possible Xeloda side effects in female

Reported by a pharmacist from United States on 2012-07-20

Patient: female

Reactions: Abdominal Pain, Haematochezia, Vomiting, Stomatitis, Diarrhoea, Dehydration, Dizziness

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in female

Reported by a physician from Denmark on 2012-07-19

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Diarrhoea, Aortic Arteriosclerosis, Pulmonary Congestion, Dehydration, Febrile Neutropenia, Arteriosclerosis Coronary Artery

Adverse event resulted in: death

Drug(s) suspected as cause:
Oxaliplatin
    Dosage: 130 mg/m2, tiw
    Indication: Colorectal Cancer Metastatic

Xeloda
    Dosage: 2000 mg/m2 daily once every 14 days
    Administration route: Oral
    Indication: Colorectal Cancer Metastatic



Possible Xeloda side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-16

Patient: male, weighing 63.6 kg (139.8 pounds)

Reactions: Vomiting, Nausea, Diarrhoea, Dehydration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in 66 year old female

Reported by a physician from Costa Rica on 2012-07-16

Patient: 66 year old female

Reactions: Abdominal Pain, Diarrhoea, Dehydration, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin
    Indication: Colorectal Cancer

Xeloda
    Administration route: Oral
    Indication: Colorectal Cancer

Other drugs received by patient: Oxaliplatin



Possible Xeloda side effects in female

Reported by a physician from Denmark on 2012-07-13

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Diarrhoea, Dehydration, Febrile Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Oxaliplatin
    Indication: Colorectal Cancer Metastatic

Xeloda
    Administration route: Oral
    Indication: Colorectal Cancer Metastatic



Possible Xeloda side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12

Patient: female, weighing 71.7 kg (157.8 pounds)

Reactions: Diarrhoea, Malnutrition, Dehydration, Palmar-Plantar Erythrodysaesthesia Syndrome, Colitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in female

Reported by a physician from United States on 2012-07-12

Patient: female, weighing 69.9 kg (153.8 pounds)

Reactions: Weight Decreased, Stomatitis, Anaemia, Pancytopenia, Blood Count Abnormal, Death, Mucosal Inflammation, Dehydration, Diabetes Mellitus Inadequate Control, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Aranesp



Possible Xeloda side effects in female

Reported by a individual with unspecified qualification from United Kingdom on 2012-07-11

Patient: female, weighing 75.0 kg (165.0 pounds)

Reactions: Dehydration, Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: date of last dose prior to sae: 21/jun/2012
    Indication: Gastric Cancer
    Start date: 2012-05-10

Cisplatin
    Dosage: date of last dose prior to sae: 21/jun/2012
    Indication: Gastric Cancer
    Start date: 2012-05-10

Epirubicin Hydrochloride
    Dosage: date of last dose prior to sae: 21/jun/2012
    Indication: Gastric Cancer
    Start date: 2012-05-10

Xeloda
    Dosage: date of last dose prior to sae: 28/jun/2012
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2012-05-10

Other drugs received by patient: Ranitidine; Milk Thistle; COD Liver OIL; Chondroitin + Glucosamine



Possible Xeloda side effects in

Reported by a individual with unspecified qualification from United States on 2012-07-11

Patient:

Reactions: Weight Decreased, Thrombosis, Pruritus, Hypokalaemia, Fatigue, Depression, Thrombocytopenia, Alanine Aminotransferase Abnormal, Blood Antidiuretic Hormone Abnormal, Dyspnoea, Nausea, Lymphopenia, Haemoglobin Abnormal, Hyponatraemia, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Diarrhoea, Embolism, Blood Alkaline Phosphatase Abnormal, Dehydration, Neutropenia, Leukopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on days 1-14
    Administration route: Oral
    Indication: Breast Cancer Metastatic

Xeloda
    Dosage: beginning on day 8 and continuing to day 21 (total of 14 days)
    Administration route: Oral
    Indication: Breast Cancer Metastatic



Possible Xeloda side effects in 62 year old female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-10

Patient: 62 year old female, weighing 63.0 kg (138.6 pounds)

Reactions: Lung Disorder, Escherichia Test Positive, Diarrhoea, Metastases To Liver, Aortic Arteriosclerosis, Dehydration, Febrile Neutropenia, Arteriosclerosis Coronary Artery, Pathogen Resistance

Adverse event resulted in: death

Drug(s) suspected as cause:
Oxaliplatin
    Dosage: 130 mg/m2 milligram(s)/sq. meter (3 week) intravenous (not otherwise specified)
    Indication: Colorectal Cancer Metastatic

Xeloda
    Dosage: 2000 mg/m2 milligram(s) sq. meter (14 day) oral
    Administration route: Oral
    Indication: Colorectal Cancer Metastatic



Possible Xeloda side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-10

Patient: female, weighing 86.3 kg (189.8 pounds)

Reactions: Weight Decreased, Pneumonia Aspiration, Vomiting, Nausea, Nail Discolouration, Malnutrition, Convulsion, Ileus, Dehydration, Onychoclasis, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Coumadin



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017